Showing results (671-680 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|November 5, 2020
Development of a Severity Classification System for Sickle Cell DiseaseNirmish Shah, David Beenhouwer, Michael S Broder, et al.Clinicoeconomics and Outcomes Research : CEOR|October 28, 2021
The Recovery Room: Transition from a Sleepy Postoperative Unit to a Vibrant and Cost-Effective Multipurpose Perioperative Care UnitStefan Schad, Hendrik Booke, Serge C Thal, et al.Clinicoeconomics and Outcomes Research : CEOR|October 29, 2021
Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer's PerspectiveBhavani Shankara Bagepally, Usa Chaikledkaew, Sitaporn Youngkong, et al.Clinicoeconomics and Outcomes Research : CEOR|July 11, 2022
Financial Burden and Catastrophic Health Expenditure Associated with COVID-19 Hospitalizations in Kerala, South IndiaRonnie Thomas, Quincy Mariam Jacob, Sharon Raj Eliza, et al.Clinicoeconomics and Outcomes Research : CEOR|September 24, 2015
Estimating the health care burden of prescription opioid abuse in five European countriesAmie Shei, Matthew Hirst, Noam Y Kirson, et al.Clinicoeconomics and Outcomes Research : CEOR|October 28, 2015
Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in JapanAtaru Igarashi, Manabu Akazawa, Tatsunori Murata, et al.Clinicoeconomics and Outcomes Research : CEOR|January 8, 2015
Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohortMonica Tontodonati, Giovanni Cenderello, Benedetto Maurizio Celesia, et al.Clinicoeconomics and Outcomes Research : CEOR|August 29, 2015
A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomesWah Fung Tse, Weimin Yang, Wenlong HuangClinicoeconomics and Outcomes Research : CEOR|July 31, 2014
Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumoniaJunji Lin, Yunfeng Li, Haijun Tian, et al.Clinicoeconomics and Outcomes Research : CEOR|December 26, 2013
Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer painJosep Darbà, Lisette Kaskens, Rainel Sánchez-de la RosaPageof 102